The global poultry diagnostics market is anticipated to grow at 9% CAGR between 2021 and 2031 to reach valuation of nearly US$ 660 Mn by 2031. In the last 5 years, the market expanded at 8.3% CAGR and surpassed valuation of US$ 358 Mn in 2020.
Poultry disease outbreaks are key factors fuelling the demand for effective poultry diagnostics solutions. The global poultry industry is suffering as a result of rising prevalence of various ailments. Ongoing attempts intended at increasing farmer knowledge about these illnesses, caused by a variety of bacteria, viruses, fungi, environmental stress, protozoon pathogens, and nutritional deficiencies have proven crucial for growth of the poultry diagnostics market.
Foodborne and zoonotic diseases are often associated with poultry. Eradication of foodborne and zoonotic pathogens is presenting a major challenge to the poultry industry.
Request a report sample to gain comprehensive insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=6747
Zoonotic means that the disease can be passed from one species to another. Diseases affecting poultry also have negative health implications on consumers of poultry products. One of the most common infections in chickens is salmonella. Also, Marek’s disease and avian reticulon endotheliosis are among common ailments affecting health in birds. These infectious can cause cancer-like illnesses, which is most commonly reported in chickens.
Rising occurrence of such illnesses is posing a serious danger to the poultry sector and as a result, demand for poultry diagnostics is increasing. Focus on eliminating the risk of aforementioned diseases and ascertaining healthy source of food items for consumers will therefore remain chief growth drivers.
Key takeaways from Poultry Diagnostics Market Research Report
- With a market share of more than 35%, North America dominates the global poultry diagnostics market.
- Over the projected period, demand for poultry diagnostics in Asia Pacific is expected to grow at an impressive CAGR of 11%.
- Europe is a leading exporter of poultry products and one of the world’s top poultry producers. It therefore presents conducive environment for expansion of the poultry diagnostics market. Within Europe, the U.K. will remain a lucrative pocket.
- China poultry diagnostic market is expected to reach US$ 139 million by 2031.
- In 2020, the market in the U.S. is expected to be worth US$ 97 million.
- By test, enzyme-linked adsorption assay (ELISA) holds 52% of total market share and is estimated to grow at 10% CAGR in forecast period
- By disease, avian influenza accounts for over 27% of total market share.
Growth Drivers:
- Increasing government efforts towards animal welfare and spreading awareness about poultry diseases are aiding market growth.
- Expansion of the meat industry and high demand and usage of eggs across diverse sectors, including food and personal care are projected to drive market growth.
- With a wide spectrum of illnesses that might harm the stock, advances in toxicology, serology, pathology, and microbiology will have an impact on long-term need for poultry diagnostics.
Speak to the expert:
https://www.factmr.com/connectus/sample?flag=AE&rep_id=6747
Competitive Landscape
Key players are adopting key strategies such as collaborations, mergers, and acquisitions to develop products and increase market revenue. For instance,
- In July 2018, in order to enhance its position in the field of veterinary diagnostics, Zoetis finalized the purchase of Abaxis, a global manufacturer of on-site veterinary testing equipment.
- In March 2018, for avian samples, BioChek has released a salmonella enteritidis-typhoid-heidelberg DNA test kit and an infectious bronchitis virus RNA test kit.
- In February 2018, Biochek launched avian influenza H5-H7-H9 multiplex, a PCR test kit to diagnose avian influenza.
Key players operating in the poultry diagnostics market include
- IDEXX Laboratories
- QIAGEN N.V.
- Thermo Fisher Scientific
- Zoetis
- GD Animal Health
- IDvet
- AffiniTech LTD
- AgroBioTek Internacional
- BioNote
- BioChek
- Boehringer Ingelheim
- MEGACOR Diagnostik GmbH
- BioInGenTech Biotechnologies.
For customized report: https://www.factmr.com/connectus/sample?flag=RC&rep_id=6747
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
